Creatinine Test Market, By Test Type (Blood test, and Urine test), By Instruments, (Clinical Analyzer, Creatinine Test Strips, and Cartridge) By Indication (Kidney Disease, Kidney Failure and Urinary Tract Obstruction) By End User (Hospital & Clinics, Diagnostic Center, and Research Institutes), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI9418 | Publish Date: April 2024 | No. of Pages: 180

Global Creatinine Test Market By Overview

Introduction:

Creatinine Test Market was valued at US$ 1250.4 Million in 2024 and is projected to grow at a CAGR of 17.4% to reach US$ 6212.9 million by 2034.

Creatinine is a chemical waste molecule generated from the muscle metabolism, produced from creatine. The creatinine is transported through the bloodstream to the kidneys, where the kidney filter out the most of the creatinine and is disposed in the urine. Hence the creatinine test is performed for both blood and urine. The creatinine blood test is carried out to keep a check whether the blood creatinine level is in a normal range. The level of creatinine is known as a reliable indicator for kidney function. As the body does not recycle the creatinine it is excreted in the urine.

Creatinine Test Market - Introduction

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global Creatinine Test Market By Dynamics

Further, the increasing application of creatinine test is expected to foster the growth of creatinine test market. For instance, the elevated levels of creatinine in the adult’s males have been linked to prostate cancer, while the elevated levels in infants are associated with bacteremia. The creatinine level in the blood is also raised due high blood pressure and diabetes. Therefore, the increasing prevalence of diabetics supports the growth of creatinine test market. Moreover, the some drugs, such as cimetidine (Bactrim) can abnormally elevate the creatinine levels.

The creatinine urine test is also used to detect indication such, as kidney infection, kidney failure, and urinary tract obstruction, such as kidney stone.

Market drivers that are expected to foster the growth of creatinine market in the near future

As according to Center for Disease Control and Prevention in year 2017 the 30 Mn of people or 15% of the US adults were estimated to have chronic kidney disease, which supports increasing the demand of creatinine test market. Further, the leading cause of kidney failure is diabetes and high blood pressure. According to American Kidney Fund’s disease, in 2012 the primary cause for 239,837 kidney failure was diabetes and the primary cause for 159,049 kidney failure patients was high blood pressure. Therefore, increasing prevalence of diabetes and high blood pressure in turn supports the growth of creatinine test market.

Further, the increasing awareness regarding the kidney disease favors the growth of creatinine test market. For instance, World kidney day a global awareness campaign conducted in March 2018 for creating the awareness regarding the kidney related disease.

The increasing demand of point-of-care device for creatinine test is expected to augment the market for creatinine test market. For instance, in July 2017 Radiometer commercially launched the CE marked point-of-care tests for creatinine and urea. Further, as the point-of-care devices provide quick and accurate result. The Radiometer’s ABL90 FLEX PLUS analyzer provides rapid analysis of 19 parameters from 67 µl of blood, with the results obtained in 35 seconds. Such advancement with point-of-care devices is expected to further spur the growth of creatinine test market in the near future.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Creatinine Test Market By Segmentation

Creatinine Test Market is segmented based on Test type, instruments, indication, end user and region.

Market Taxonomy for Creatinine Test Market

By Test Type

• Blood Test

• Urine Test

By Instruments

• Clinical Analyzer

• Creatinine Test Strips

• Cartridge

By Indication

• Kidney Disease

• Kidney Failure

• Urinary Tract Obstruction

By End User

• Hospitals & Clinics

• Diagnostic Center

• Research Institutes

Regional Insights:

Creatinine Test Market - Regional Insights

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

The North America is expected to dominate the creatinine test market followed by Europe and Asia Pacific owing to the technological advancements, with high prevalence of chronic kidney disease. As according to Center for Disease Control and Prevention in 2015 the number of adults diagnosed with kidney disease is 4.9Mn. Further the Europe is estimated to be at second position in the creatinine market. Owing to increased expenditure in research and development by the Europe government is also expected to favor the growth of creatinine test market. As in 2016, the European government spent U.S $369.6Bn on the research and development.

The Asia Pacific region is expected to show the fastest growth overall the region, due increasing prevalence of kidney related disease. Further, with increasing investment in healthcare facilities by government also favors the growth of Creatinine test market in Asia Pacific region.

Further, the Middle East and Africa are the untapped region, which provides opportunity to the local players to penetrate within the market of creatinine test market in Middle East region, with low price of creatinine test.

The availability of alternative option to the creatinine test is expected to hamper the growth of creatinine test market. For instance, in January 2018, IDEXX launched SDMA in the point-of-care with IDEXX catalyst SMDA test, which is available in North America for advanced kidney test, which is proven to identify kidney disease earlier than the creatinine test. The further, geographical expansion of IDEXX catalyst SMDA test could hamper the creatinine test market in the near future.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Market Size 2024

US$ 1250.4 million

Projected Market Size 2034

US$ 6212.9 million

CAGR Growth Rate

17.4%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Billion & CAGR from 2024 to 2034

Market Segmentation

By Test Type - Blood test, and Urine test

By Instruments - Clinical Analyzer, Creatinine Test Strips, and Cartridge

By Indication -  Kidney Disease, Kidney Failure and Urinary Tract Obstruction

By End User -  Hospital & Clinics, Diagnostic Center, and Research Institutes

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Creatinine Test Market report based on Test type, instruments, indication, end user and region:

Creatinine Test Market, By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa

Global Creatinine Test Market By Key Players

The key players operating the creatinine test market, include Beckman Coulter, Quest Diagnostics, Bayer, Merck, Abbott, Sonic Healthcare, Laboratory Corporation of America Holdings, Genoptix, Healthscope, Charles River, OPKO Health, Inc., and Labco.

Global Creatinine Test Market By Key Issues Addressed

Recent Development:

  • In March 2023, Phoenix, Arizona-based Dignity Health St. Joseph’s Hospital and Medical Center launched a new initiative this week to address the use of race-based algorithms in the early diagnosis of chronic kidney disease (CKD) and combatting health disparities. It is designed to help improve health equity and outcomes for Black patients. Diagnosing kidney disease can be complicated by the use of biased assessment tools, such as the estimated glomerular filtration rate (eGFR).

Global Creatinine Test Market By Company Profile

  • Bayer*
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Beckman Coulter
  • Quest Diagnostics
  • Merck
  • Abbott
  • Sonic Healthcare
  • Laboratory Corporation of America Holdings
  • Genoptix
  • Healthscope
  • Charles River
  • OPKO Health Inc.,
  • Labco.

“*” marked represents similar segmentation in other categories in the respective section.

Global Creatinine Test Market By Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Test Type
      • Market Snippet, By Instruments
      • Market Snippet, By Indication
      • Market Snippet, By End-User
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Test Type
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
      • Y-o-Y Growth Analysis (%), 2024 – 2034
      • Segment Trends
    • Blood Test
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Urine Test
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
  6. Market Segmentation, By Instruments, 2024 – 2034, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
      • Y-o-Y Growth Analysis (%), 2024 – 2034
      • Segment Trends
    • Clinical Analyzer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Creatinine Test Strips
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Cartridge
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
  7. Market Segmentation, By Indication, 2024 – 2034, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
      • Y-o-Y Growth Analysis (%), 2024 – 2034
      • Segment Trends
    • Kidney Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Kidney Failure
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Kidney Failure and Urinary Tract Obstruction
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
  8. Market Segmentation, By End-User, 2024 – 2034, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
      • Y-o-Y Growth Analysis (%), 2024 – 2034
      • Segment Trends
    • Hospital & Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Diagnostic Center
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
    • Research Institutes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2024 – 2034
  9. Global Market, By Region, 2024 – 2034, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2024 – 2034
      • Y-o-Y Growth Analysis (%), 2024 – 2034
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Instruments, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Indication, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By End-User, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Instruments, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Indication, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By End-User, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Instruments, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Indication, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By End-User, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Instruments, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Indication, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By End-User, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Instruments, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Indication, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By End-User, 2024 – 2034
      • Market Size and Forecast (US$ Mn), By Country, 2024 – 2034
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Beckman Coulter
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Quest Diagnostics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sonic Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Laboratory Corporation of America Holdings
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Genoptix
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Healthscope
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Charles River
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • OPKO Health, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Labco
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

FAQs

The market is segmented into By Test Type (Blood test, and Urine test), By Instruments, (Clinical Analyzer, Creatinine Test Strips, and Cartridge) By Indication (Kidney Disease, Kidney Failure, Kidney Failure and Urinary Tract Obstruction) By End User (Hospital & Clinics, Diagnostic Center, and Research Institutes)

The increasing application of creatinine test is expected to faster the growth of creatinine test market

The North America dominates the cell culture market owing to increasing presence of biopharmaceutical industries with increasing demand of precision medicine.

The key players operating the creatinine test market, include Beckman Coulter, Quest Diagnostics, Bayer, Merck, Abbott, Sonic Healthcare, Laboratory Corporation of America Holdings, Genoptix, Healthscope, Charles River, OPKO Health, Inc., and Labco.

Lack of Awareness might hamper the market.